AUTOMATIC VOLUME PRICING◆3–5 VIALS SAVE 5%◆6–9 SAVE 7%◆10–19 SAVE 10%◆20+ SAVE 12%◆UNIFORM 3 ML VIALS◆RESEARCH USE ONLY◆
RESEARCH
ARSENAL

Documentation

COA STATUS

A documentation library that says what is ready—and what is not.

Batch-specific third-party reports are being acquired. Until a product-matched report is ready, the catalog shows it as pending instead of filling the gap with a borrowed, generic, or placeholder certificate.

The current workaround is transparency.

Every approved product appears in the registry below. A status changes only when the report can be matched to that product and batch. No purity percentage or testing badge is published without the record behind it.

Current catalogDocumentation rollout in progress

No borrowed, placeholder, or cross-batch reports are displayed. Each status changes only when a product-matched batch record is ready to publish.

  • BPC-157Report pending
  • TB-500Report pending
  • CJC-1295 (No DAC)Report pending
  • IpamorelinReport pending
  • GHRP-2Report pending
  • GHRP-6Report pending
  • HexarelinReport pending
  • SermorelinReport pending
  • TesamorelinReport pending
  • IGF-1 LR3Report pending
  • PEG-MGFReport pending
  • MOTS-cReport pending
  • SS-31Report pending
  • EpitalonReport pending
  • SelankReport pending
  • SemaxReport pending
  • Thymosin Alpha-1Report pending
  • KPVReport pending
  • AOD-9604Report pending
  • RetatrutideReport pending
  • CagrilintideReport pending
  • TirzepatideReport pending
  • SemaglutideReport pending

WHEN REPORTS ARRIVE

How records will connect to the vial.

01

Product match

The report must identify the same compound and strength as the catalog entry.

02

Batch match

The lot reference on the report must connect to the identifier used on the vial or order record.

03

Method context

The testing method, laboratory, dates, and measured values stay visible with the original report.

04

Public status

The registry changes from pending to published and links to the batch-specific document.